Ottobock stock: Jefferies kept EUR 83.00 target for Ottobock stock
Published on 10/20/2026 at 15:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSJefferies target and report date
- Jefferies kept an EUR 83.00 Buy target for Ottobock on September 15, 2026.
- Fiscal year 2025 core revenue reached EUR 260.00 million, up 11.70 percent.
- Ottobock stock costs EUR 51.00 at Lang & Schwarz on October 20, 2026 at 3:05 p.m. CEST, down 2.30 percent versus the Xetra close of October 19, 2026 at EUR 52.20.
- Ottobock is scheduled to publish its third-quarter 2026 report on November 12, 2026.
Jefferies kept its Buy rating and EUR 83.00 price target for Ottobock on September 15, 2026, putting the target 62.75 percent above the EUR 51.00 Lang & Schwarz price. The analyst action was reported by MarketScreener.
At Lang & Schwarz, Ottobock traded at EUR 51.00 on October 20, 2026 at 3:05 p.m. CEST, down 2.30 percent versus the Xetra close of October 19, 2026 at EUR 52.20.
Revenue and earnings provide context
In fiscal year 2025, Ottobock reported core revenue of EUR 260.00 million, an increase of 11.70 percent. Adjusted core EBITDA reached EUR 67.02 million, up 29.50 percent from the prior fiscal year, while adjusted group profit rose to EUR 28.60 million, an increase of 83.20 percent, according to Ottobock.
Stock sits below its yearly high
The stock's 52-week range was EUR 45.80 to EUR 75.95 as of October 19, 2026. At EUR 51.00, the price stood 32.85 percent below the high and 11.35 percent above the low. The same date's market capitalization was EUR 3.35 billion, with a normalized price-to-earnings ratio of 21.03 and a trailing dividend yield of 1.85 percent.
Valuation and upcoming dates
Jefferies' EUR 83.00 target remains the clearest near-term valuation reference. Ottobock is scheduled to publish its third-quarter 2026 report on November 12, 2026, according to Ottobock. The company also lists a BNP Paribas MidCap CEO Conference on November 16, 2026 and the Jefferies Global Healthcare Conference from November 18 to November 19, 2026.
What the target means for valuation
The EUR 83.00 target is 62.75 percent above the October 20 Lang & Schwarz price, while the stock remains 32.85 percent below its 52-week high. That gap places the upcoming third-quarter report at the center of the next scheduled review, particularly after the fiscal year 2025 improvement in adjusted earnings.
Price and scheduled reports
Ottobock traded at EUR 51.00 at Lang & Schwarz on October 20, 2026 at 3:05 p.m. CEST, down 2.30 percent versus the Xetra close of October 19, 2026 at EUR 52.20. The November 12, 2026 reporting date is the next defined company event.
The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.
Ottobock stock at a glance
- Company: Ottobock SE & Co. KGaA
- ISIN: DE000BCK2223
- Ticker: OBCK.DE
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 20, 2026, 3:05 p.m. CEST: EUR 51.00
- Change versus Xetra close: minus 2.30 percent
- Xetra close October 19, 2026: EUR 52.20
- Market capitalization: EUR 3.35 billion as of October 19, 2026
- 52-week range: EUR 45.80-75.95 as of October 19, 2026
- Sector / Industry: Healthcare / Medical Instruments & Supplies
- Next earnings date: November 12, 2026
Market context: Market report DAX.
